Evidence map›Paper›PMID 33355448›Full record

ArticleACS applied materials & interfaces2021

Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use.

Bedia Begüm Karakoçak, Amine Laradji, Tina Primeau, Mikhail Y Berezin, Shunqiang Li, Nathan Ravi

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 122 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Stalk-derived carbon dots as nanosensors for FeFrontiers in bioengineering and biotechnology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bedia Begüm KarakoçakDepartment of Ophthalmology and Visual Sciences, Washington University in St. Louis, St. Louis, Missouri 63110, United States.ORCID http://orcid.org/0000-0001-9676-7465
Amine LaradjiDepartment of Ophthalmology and Visual Sciences, Washington University in St. Louis, St. Louis, Missouri 63110, United States.
Tina PrimeauDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Mikhail Y BerezinDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Shunqiang LiDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Nathan RaviDepartment of Ophthalmology and Visual Sciences, Washington University in St. Louis, St. Louis, Missouri 63110, United States.ORCID http://orcid.org/0000-0003-3923-6224
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft ModelsU54CA224083 · NCI · WASHINGTON UNIVERSITY · PI Kian-Huat Lim · 2017 to 2026
$13.0M
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHYR01CA208623 · NCI · WASHINGTON UNIVERSITY · PI BEREZIN, MIKHAIL Y. · 2017 to 2021
$2.2M
Development of a Biomimetic Vitreous SubstituteR01EY021620 · NEI · WASHINGTON UNIVERSITY · PI RAVI, NATHAN · 2013 to 2015
$1.1M
FLUORESCENCE SPECTROPHOTOMETER IN NIR RANGE FOR BIOLOGICAL AND MEDICAL APPLICATIOS10RR031621 · NCRR · WASHINGTON UNIVERSITY · PI BEREZIN, MIKHAIL Y. · 2011 to 2011
$292k
NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA208623NCI NIH HHS U54 CA224083NCRR NIH HHS S10 RR031621NEI NIH HHS R01 EY021620
6 · The paper itself

Abstract

This work demonstrates the application of hyaluronan-conjugated nitrogen-doped carbon quantum dots (HA-nCQDs) for bioimaging of tumor cells and illustrates their potential use as carriers in targeted drug delivery. Quantum dots are challenging to deliver with specificity, which hinders their application. To facilitate targeted internalization by cancer cells, hyaluronic acid, a natural ligand of CD44 receptors, was covalently grafted on nCQDs. The HA-nCQD conjugate was synthesized by carbodiimide coupling of the amine moieties on nCQDs and the carboxylic acids on HA chains. Conjugated HA-nCQD retained sufficient fluorescence, although with 30% lower quantum efficiency than the original nCQDs. Confocal microscopy showed enhanced internalization of HA-nCQDs, facilitated by CD44 receptors. To demonstrate the specificity of HA-nCQDs toward human tumor cells, patient-derived breast cancer tissue with high-CD44 expression was implanted in adult mice. The tumors were allowed to grow up to 200-250 mm

Indexed as

AnimalsCarbonCell Line, TumorCHO CellsContrast MediaCricetulusFemaleFluorescent DyesHumansHyaluronan ReceptorsHyaluronic AcidMiceMicroscopy, ConfocalMicroscopy, FluorescenceNeoplasmsNIH 3T3 CellsCarbonCD44 protein, humanContrast MediaFluorescent DyesHyaluronan ReceptorsHyaluronic Acidbioimagingbreast cancercancercarbon quantum dotsCD44 receptorshyaluronic acidtumor imaging

Identifiers

PMID33355448
PMCPMC8243741
OpenAlexW3117706574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.